NLRC4 Gene
Introduction
The NLRC4 (NLR Family CARD Domain Containing 4) gene encodes a critical pattern recognition receptor that forms the NLRC4 inflammasome, a multiprotein complex essential for innate immunity and inflammatory responses. While primarily studied in the context of bacterial infection, emerging research reveals important roles for NLRC4 in neuroinflammation and neurodegenerative diseases[@broz2016].
<div class="infobox infobox-gene">
<div class="infobox-header">NLRC4</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> NLR Family CARD Domain Containing 4</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 2p22.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 584821</div>
<div class="infobox-row"><strong>OMIM:</strong> 606831</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000102948</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q9NPP6</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, ALS, Neuroinflammation</div>
</div>
</div>
Overview
...NLRC4 Gene
Introduction
The NLRC4 (NLR Family CARD Domain Containing 4) gene encodes a critical pattern recognition receptor that forms the NLRC4 inflammasome, a multiprotein complex essential for innate immunity and inflammatory responses. While primarily studied in the context of bacterial infection, emerging research reveals important roles for NLRC4 in neuroinflammation and neurodegenerative diseases[@broz2016].
<div class="infobox infobox-gene">
<div class="infobox-header">NLRC4</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> NLR Family CARD Domain Containing 4</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 2p22.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 584821</div>
<div class="infobox-row"><strong>OMIM:</strong> 606831</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000102948</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q9NPP6</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, ALS, Neuroinflammation</div>
</div>
</div>
Overview
Mermaid diagram (expand to render)
NLRC4 (also known as IPAF - ICE protease-activating factor) is a member of the NLR (NOD-like receptor) family of proteins. Unlike [NLRP3](/entities/nlrp3-inflammasome) which responds to diverse stressors, NLRC4 has specialized recognition capabilities for bacterial pathogen-associated molecular patterns (PAMPs), particularly flagellin from flagellated bacteria and components of the type III secretion system (T3SS)[@vance2015].
Protein Structure
NLRC4 contains several functional domains:
N-terminal pyrin domain (PYD) - Mediates interactions with other PYD-containing proteins like ASC
NACHT domain - ATPase domain required for oligomerization and inflammasome assembly
LRR domain (Leucine-Rich Repeat) - Pattern recognition module for detecting bacterial components
C-terminal CARD domain - Direct interaction with caspase-1The NACHT domain undergoes conformational changes upon ATP binding, enabling NLRC4 oligomerization into a wheel-like structure that serves as a platform for caspase-1 activation[@hu2015].
Function
Inflammasome Assembly
NLRC4 forms inflammasomes in response to bacterial flagellin or T3SS rod proteins:
- Pattern recognition - LRR domain detects bacterial components
- Oligomerization - Activated NLRC4 recruits ASC (PYCARD) via PYD interactions
- Caspase-1 activation - NLRC4 CARD domain directly interacts with caspase-1
- Pyroptosis - Activated caspase-1 cleaves gasdermin D, causing pyroptotic cell death
- Cytokine maturation - Caspase-1 processes pro-IL-1β and pro-IL-18 into active forms
Signaling Pathways
The NLRC4 inflammasome activates multiple downstream pathways:
- Caspase-1 activation → IL-1β/IL-18 release and pyroptosis
- [NF-κB](/entities/nf-kb) activation (indirect) → inflammatory gene transcription
- MAPK pathways → cytokine production
- Cross-talk with NLRP3 - potential co-activation in some contexts
Disease Associations
Alzheimer's Disease
NLRC4 inflammasome activation contributes to chronic neuroinflammation in AD:
- Detected in AD patient brain tissue and [microglia](/cell-types/microglia-neuroinflammation)
- May be activated by [Aβ](/proteins/amyloid-beta) oligomers alongside NLRP3
- Contributes to chronic cytokine release
- Deleting NLRC4 reduces inflammation in AD mouse models
- Potential therapeutic target for modulating microglial inflammation[@heneka2013]
Parkinson's Disease
In PD, NLRC4 plays complex roles:
- Activated in microglia surrounding dopaminergic [neurons](/entities/neurons)
- May contribute to neuroinflammation-induced neuronal death
- Some studies suggest protective roles in specific contexts
- Interaction with [α-synuclein](/proteins/alpha-synuclein) pathology
- Therapeutic targeting may reduce microglial overactivation[@sun2020]
Amyotrophic Lateral Sclerosis (ALS)
NLRC4 in ALS:
- Elevated NLRC4 expression in ALS patient microglia and motor [cortex](/brain-regions/cortex)
- Contributes to inflammatory motor neuron injury
- Activated in SOD1 and [C9orf72](/entities/c9orf72) models
- Inflammasome inhibition shows promise in preclinical models
- May interact with other NLR proteins in disease progression[@debye2019]
Inflammatory Bowel Disease
While not directly neurodegenerative, NLRC4 mutations cause early-onset enterocolitis (NLRC4-related autoinflammatory disease, NLRC4-AD), demonstrating the critical role of this inflammasome in human health[@canna2014].
Expression
Cellular Distribution
NLRC4 expression patterns:
- Highest in: Macrophages, monocytes, neutrophils
- Moderate in: Dendritic cells, some epithelial cells
- Low in: Most parenchymal cells including neurons
Brain Expression
In the brain:
- Primarily expressed in [microglia](/entities/microglia)
- Minimal expression in [astrocytes](/entities/astrocytes) under normal conditions
- Induction in infiltrating immune cells during inflammation
- Cell type-specific regulation during neurodegeneration
Therapeutic Implications
Targeting NLRC4
NLRC4 represents a promising therapeutic target:
Small molecule inhibitors:
- MCC950 (primarily NLRP3, may have off-target effects)
- Compound 3d (specific NLRC4 inhibitor)
- Doxycycline (demonstrates NLRC4 inhibition)
Therapeutic strategies:
- Reduce harmful neuroinflammation
- Maintain host defense capabilities
- Balance pro-inflammatory vs. protective immunity
- Brain-penetrant compounds needed
Combination approaches:
- Dual NLRP3/NLRC4 inhibitors
- Combined with disease-modifying therapies
- Timing considerations (acute vs. chronic inflammation)
See Also
- [NLRP3 Inflammasome](/mechanisms/nlrp3-inflammasome-pathway)
- [Inflammasome Pathway](/mechanisms/inflammasome-pathway)
- [Neuroinflammation](/mechanisms/microglia-neuroinflammation)
- [CASP1 Gene](/genes/casp1)
- [PYCARD Gene (ASC)](/genes/pycard)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [NCBI Gene: NLRC4](https://www.ncbi.nlm.nih.gov/gene/584821)
- [UniProt: Q9NPP6](https://www.uniprot.org/uniprot/Q9NPP6)
- [Ensembl: ENSG00000102948](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102948)
- [Human Protein Atlas: NLRC4](https://www.proteinatlas.org/gene/ENSG00000102948-NLRC4)
Background
The study of Nlrc4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Broz P, Dixit VM. (2016). Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 16(7):407-420, https://pubmed.ncbi.nlm.nih.gov/27291964/ (2016)](https://pubmed.ncbi.nlm.nih.gov/27291964/)
[Vance RE. (2015). The NAIP/NLRC4 inflammasomes. Curr Opin Immunol. 32:84-89, https://pubmed.ncbi.nlm.nih.gov/25950453/ (2015)](https://pubmed.ncbi.nlm.nih.gov/25950453/)
[Hu Z, et al. (2015). Structural and biochemical basis for induced self-propagation of NLRC4. Science. 350(6262):404-409, https://pubmed.ncbi.nlm.nih.gov/26449475/ (2015)](https://pubmed.ncbi.nlm.nih.gov/26449475/)
[Heneka MT, et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 493(7433):674-678, https://pubmed.ncbi.nlm.nih.gov/23254930/ (2013)](https://pubmed.ncbi.nlm.nih.gov/23254930/)
[Sun L, et al. (2020). NLRC4 inflammasome contributes to dopaminergic neuronal death via promoting neuroinflammation in Parkinson's disease models. J Neuroinflammation. 17(1):258, https://pubmed.ncbi.nlm.nih.gov/32791956/ (2020)](https://pubmed.ncbi.nlm.nih.gov/32791956/)
[Debye B, et al. (2019). Inflammasome activation in amyotrophic lateral sclerosis. Acta Neuropathol. 138(3):363-378, https://pubmed.ncbi.nlm.nih.gov/31115772/ (2019)](https://pubmed.ncbi.nlm.nih.gov/31115772/)
[Canna SW, et al. (2014). An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 46(10):1140-1146, https://pubmed.ncbi.nlm.nih.gov/25217959/ (2014)](https://pubmed.ncbi.nlm.nih.gov/25217959/)Pathway Diagram
The following diagram shows the key molecular relationships involving NLRC4 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)